Patents Assigned to Merck Patent Gesellschaft met beschrankter haftung
  • Patent number: 5725796
    Abstract: The invention relates to a liquid-crystal display based on a twisted nematic cell and havingtwo substrates provided with electrode layers and alignment layers thereon and, with a frame, forming a cell,a nematic liquid-crystal mixture having positive dielectric anisotropy present in the cell, anda twist angle of the liquid-crystal layer in the cell with a value of between 0.degree. and 600.degree. from alignment layer to alignment layer,whose liquid-crystal mixture is based on medium-polarity compounds of the SFM type which are selected so that the liquid-crystal mixture has a viscosity at 20.degree. C. of less than 30 mm.sup.2 s.sup.-1 and has a value ofK/.DELTA..di-elect cons..ltoreq.1.5for the quotient of the Frank constant K ##EQU1## and the dielectric anisotropy .DELTA..di-elect cons..DELTA..di-elect cons.=.di-elect cons..vertline.-.di-elect cons..sub..perp.when used in a TN cell (.nu.=.pi./2, d/p<<1)K/.DELTA..di-elect cons..ltoreq.1.5where .nu.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: March 10, 1998
    Assignee: Merck Patent Gesellschaft met beschrankter Haftung
    Inventors: Ulrich Finkenzeller, Herbert Plach, Eike Poetsch, Volker Reiffenrath
  • Patent number: 4788000
    Abstract: A liquid-crystal composition to be used in a multiplex-driving system in a twisted nematic (TN) type liquid-crystal display devices is extremely superior in its display characteristics, and is able to meet sufficiently the demands to increase the information content of various liquid-crystal display devices of high-level multiplexing operation. The liquid-crystal composition is more considerable in its usefulness than the validity thereof in half-tone display especially when it is used in a liquid-crystal television.The liquid crystal composition having a positive dielectric anisotropy in the nematic phase, comprises each 3 wt % or more of 2-(4-alkoxyphenyl)-5-alkylpyrimidine compound and of a cyanobiphenyl compound.
    Type: Grant
    Filed: August 15, 1986
    Date of Patent: November 29, 1988
    Assignees: Sharp Kabushiki Kaisha, Merck Patent Gesellschaft met beschrankter haftung
    Inventors: Yutaka Ishii, Fumiaki Funada, Masataka Matsuura